Amazing Developments Made Possible By Support From The Fund For Ophthalmic Knowledge

BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi This research demonstrated, for the first time, the molecular mutations found in melanocytic malignancies of the conjunctiva.

Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment Vitreous disease in retinoblastoma is the most common reason for having to remove an eye. This work classifies vitreous disease and emphasizes that the response to treatment and outcome depends on this classification scheme.

Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy MEK inhibitors are now commonly used to treat adult cancers but have as a side effect toxicity to the retina. This work identified the unique pattern of abnormalities caused by these drugs and explained how to differentiate it from other similar but different retinal abnormalities.